Mesa Laboratories, Inc. Stock Analysis & AI Score
Mesa Laboratories, Inc. (MLAB) has an ST Score of 56.3 (B-), driven by its Profitability (A) and held back by its Growth (C-). Analysts rate it Hold with a $110.00 price target (-20.0% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Mesa Laboratories, Inc. (MLAB) has an ST Score of 56.3 (B-), driven by its Profitability (A) and held back by its Growth (C-). Analysts rate it Hold with a $110.00 price target (-20.0% downside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthC-
All factor grades
- ProfitabilityA
- MomentumA
- ForecastC
- ValuationC-
- Financial StrengthC-
- GrowthC-
- Piotroski7/9
Contact
MLAB stock: frequently asked questions
What is MLAB's ST Score?
Mesa Laboratories, Inc. (MLAB) has an ST Score of 56.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MLAB a buy, hold, or sell?
Analysts rate MLAB a Hold, with a price target of $110.00 (-20.0% vs the current price). Our ST Score grades it B- (56.3/100). The ST Score is a data-driven signal, not a recommendation.
What are MLAB's factor grades?
Valuation C-, Profitability A, Financial Strength C-, Momentum A, Growth C-, Forecast C.
What is MLAB's valuation grade?
Mesa Laboratories, Inc. (MLAB) earns a valuation grade of C-, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MLAB's growth grade?
Mesa Laboratories, Inc. (MLAB) earns a growth grade of C-, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MLAB's profitability grade?
Mesa Laboratories, Inc. (MLAB) earns a profitability grade of A, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MLAB's financial strength grade?
Mesa Laboratories, Inc. (MLAB) earns a financial strength grade of C-, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MLAB?
The average analyst price target for Mesa Laboratories, Inc. (MLAB) is $110.00 from 8 analysts, which is -20.0% versus the recent price of $137.50.
What is MLAB's Piotroski score?
Mesa Laboratories, Inc. (MLAB) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.